Cita APA

Sriskandarajah, P., De Haven Brandon, A., MacLeod, K., Carragher, N. O., Kirkin, V., Kaiser, M., & Whittaker, S. R. (2020). Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma. BMC Cancer.

Chicago Style Citation

Sriskandarajah, Priya, Alexis De Haven Brandon, Kenneth MacLeod, Neil O. Carragher, Vladimir Kirkin, Martin Kaiser, i Steven R. Whittaker. "Combined Targeting of MEK and the Glucocorticoid Receptor for the Treatment of RAS-mutant Multiple Myeloma." BMC Cancer 2020.

Cita MLA

Sriskandarajah, Priya, et al. "Combined Targeting of MEK and the Glucocorticoid Receptor for the Treatment of RAS-mutant Multiple Myeloma." BMC Cancer 2020.

Atenció: Aquestes cites poden no estar 100% correctes.